The risks and benefits of antithrombotic therapy in chronic atrial fibrillation

G J Hankey, N J Gray

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

As the risks of adverse effects of warfarin and aspirin in certain patients with chronic atrial fibrillation are high, intervention with these agents should be targeted towards those who will derive most benefit. Clearer guidelines are emerging to identify those patients and to standardise current prescribing practices.

Original languageEnglish
Pages (from-to)624-6
Number of pages3
JournalThe Medical journal of Australia
Volume164
Issue number10
Publication statusPublished - 20 May 1996

Fingerprint Dive into the research topics of 'The risks and benefits of antithrombotic therapy in chronic atrial fibrillation'. Together they form a unique fingerprint.

  • Cite this